Establishment and characterization of gemcitabine-resistant human cholangiocarcinoma cell lines with multidrug resistance and enhanced invasiveness-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Establishment and characterization of gemcitabine-resistant human cholangiocarcinoma cell lines with multidrug resistance and enhanced invasiveness

Published:2015-05-22 Issue:1 Volume:47 Page:398-410
ISSN:1019-6439
Container-title:International Journal of Oncology
language:en
Short-container-title:

Author:

WATTANAWONGDON WAREEPORN,HAHNVAJANAWONG CHARIYA,NAMWAT NISANA,KANCHANAWAT SIRIMAS,BOONMARS THIDARUT,JEARANAIKOON PATCHAREE,LEELAYUWAT CHANWIT,TECHASEN ANCHALEE,SEUBWAI WUNCHANA

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analysis of the Effector Functions of Vδ2 γδ T Cells and NK Cells against Cholangiocarcinoma Cells;Cells;2024-08-08

2. Proteomics and Bioinformatics Identify Drug-Resistant-Related Genes with Prognostic Potential in Cholangiocarcinoma;Biomolecules;2024-08-08

3. Curcumin synergistically enhances the efficacy of gemcitabine against gemcitabine-resistant cholangiocarcinoma via the targeting LAT2/glutamine pathway;Scientific Reports;2024-07-11

4. The Natural Product Parthenolide Inhibits Both Angiogenesis and Invasiveness and Improves Gemcitabine Resistance by Suppressing Nuclear Factor κB Activation in Pancreatic Cancer Cell Lines;Nutrients;2024-02-29

5. Establishment and characterization of the gemcitabine-resistant human gallbladder cancer cell line NOZ GemR;Annals of Medicine & Surgery;2024-01-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP